Quick Heal Technologies (QUICKHEAL) Q1 26/27 earnings summary

Executive summary

• Reported Q1 FY27 consolidated revenue of ₹45.0 Cr, down 21.4% YoY, with EBITDA loss of ₹17.6 Cr and PAT loss of ₹5.3 Cr; margins improved sequentially but remain negative.

• Enterprise segment showed resilience with ₹30.0 Cr revenue (-5.5% YoY), while consumer revenue declined sharply to ₹19.2 Cr (-39.3% YoY).

• Deferred revenue increased to ₹52.3 Cr, reflecting strong order book and market acceptance of new products.

• Strategic wins in Defence, BFSI, and IT services sectors; continued focus on AI-driven cybersecurity and enterprise expansion.

Financial highlights

• Gross margin remained robust at 98.2% in Q1 FY27.

• EBITDA margin improved to -39.1% from -60.2% in Q4 FY26, but still negative.

• PAT margin at -11.7%, a sequential improvement.

• Other income of ₹14.1 Cr included a significant service tax refund.

• Overdues reduced to ₹106.6 Cr, down nearly ₹70 Cr since H1 FY26.

Outlook and guidance

• Management remains focused on innovation, operational efficiency, and enterprise growth.

• Consumer demand expected to remain soft due to market headwinds; enterprise pipeline remains strong.

• Continued investment in AI, new product launches, and geographic expansion.